Medtronic saw 4.6% year-over-year revenue growth during its fiscal fourth quarter ending April 28, generating over $7.9 billion, with the fastest growth coming from its minimally invasive therapies unit. CEO Omar Ishrak said the company is making "distinct competitive advantages and capitalizing on the long-term trends in health care, namely the desire to improve outcomes; the growing demand for expanded access to care; and the optimization of cost and efficiency within health care systems."
Fiscal Q4 revenue increases for Medtronic
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.